The value of monitoring minimal residual disease in the patients with donor lymphocyte infusion as intervention of relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation

Am J Hematol. 2010 Feb;85(2):141-2. doi: 10.1002/ajh.21573.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Female
  • Follow-Up Studies
  • Graft vs Host Disease / pathology
  • Graft vs Host Disease / prevention & control
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Lymphocyte Transfusion*
  • Male
  • Middle Aged
  • Monitoring, Physiologic*
  • Neoplasm, Residual
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / pathology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
  • Recurrence
  • Transplantation, Homologous